INTRODUCTION CELL & GENE THERAPY PLATFORM CASE STUDY METHOD PACT Pharma is a clinical-stage company with the goal to treat patients with personalized neoTCR-based therapies across a broad range of tumor mutational burdens and solid cancer types. Currently PACT is conducting a phase one clinical trial with recruiting and dosing patients at multiple sites within the US. From a business priority and IT standpoint, with a heavy focus on analytics, they wanted to develop secure and compliant systems and to provide visibility into data for AI scientists and operations that create translational, clinical, and operational insights that ultimately optimize the processes. With the learnings from their clinical trials PACT wanted to focus on automation to improve throughput, and reduce needle to need

Join for free to read